The DPP-4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic doses. [electronic resource]
Producer: 20111215Description: 39-50 p. digitalISSN:- 1365-2125
- Adult
- Cross-Over Studies
- Dipeptidyl-Peptidase IV Inhibitors -- administration & dosage
- Dose-Response Relationship, Drug
- Double-Blind Method
- Electrocardiography -- drug effects
- Female
- Heart Rate -- drug effects
- Humans
- Linagliptin
- Male
- Middle Aged
- Purines -- administration & dosage
- Quinazolines -- administration & dosage
- White People
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.